Apellis has said it will seek a re-examination of the CHMP’s opinion, noting that there were “multiple dissenting voices” by members of the panel. It also said that specialists at an ad hoc ...

Johnson & Johnson JNJ announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) rendered a positive opinion for the expanded use of the ...

Bristol Myers (BMY) announced the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, has ...

The commission wants the CHMP to consider whether the information may require an update of the positive opinion, and to consider whether the wording of the risk minimization measures in the ...